Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

TRENDING TOPICS:

  • Emergency Room Boarding
  • Device Coverage by Medicare
  • Planned Parenthood Funding
  • Covid/Flu Combo Shot
  • RFK Jr. vs. Congress

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Sep 7 2022

Full Issue

Viewpoints: New Covid Booster Should Be Treated Like Yearly Flu Shot; Paxlovid Should Be Easier To Get

Editorial writers delve into covid related topics as well as other public health issues.

The Washington Post: The Updated Booster Shot Is A Reset For How To Manage Covid 

Federal health officials last week authorized a new coronavirus booster, the first time the vaccine formulation has been updated. This decision was not without controversy, but is the correct one that heralds a reset for how to manage covid-19. (Leana S. Wen, 9/6)

San Francisco Chronicle: Omicron Got Me After 2 Years As A COVID Hermit. Then, Doctors Made It Worse

I knew right away that it was going to be bad. It was a hot, humid night — almost 90 degrees — but my body was freezing. Putting on a sweatshirt and diving under a blanket couldn’t warm me up. My head, on the other hand, was on fire. I had a temperature over 100 degrees and needed ice packs piled on my forehead to cool down. The coughing wouldn’t stop. (Matthew Fleischer, 9/4)

The Washington Post: Solitary Confinement Is Torture. U.S. Prisons Should Stop Using It

Imagine spending most of the day locked in a small windowless room. There is little to no natural light, no meaningful human interaction and nothing to break the monotony of being alone. No wonder Nelson Mandela described solitary confinement as “the most forbidding aspect of prison life.” This grotesque practice is a form of torture — one that is too common in the United States. (9/6)

Modern Healthcare: Primary Care In Crisis: A Prescription For Recovery And Resilience

COVID-19 has taken a toll on the workforce across U.S. industries, from hospitality to manufacturing to retail—and healthcare is certainly no exception. Stress on the system, increased costs, labor shortages and escalated personal risk of illness created a perfect storm of higher burnout and lower resiliency among primary-care providers. (Rebecca Etz, 9/6)

Stat: Congress Should Not Compel Medicare To Pay For Liquid Biopsies 

When the two Republican senators from Mississippi cosponsor legislation with the two Democratic senators from California, something intriguing must be going on. What do these Republicans and Democrats agree on? That Medicare should be compelled to pay for liquid biopsies, which test for multiple cancers using a single vial of blood, even though no one is sure whether they work or not. (H. Gilbert Welch, 9/7)

Stat: FDA Needs To Be More Flexible Assessing Rare Disease Treatments 

Every time I read about clinical trials testing possible treatments for rare diseases, I think of my son, Ty, whose brief but successful foray into such a trial highlights their value and their devastating limitations. (Karen Quandt, 9/7)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF